PANTHER Gene Information   
Gene Symbol(s): cyp-33c5
Organism: Caenorhabditis elegans
View Gene in Tree
Tree Reduced Tree  
Tree Reduced Tree
Gene Name: CYtochrome P450 family
Gene ID: WBGene00018261
Protein ID: O16671
Persistent Id: PTN002387292
Alternate Ids:
351062952(GI) NP_503616(refSeq)
WBGene00018261(Ensembl) WBGene00018261(WormBase)
178706(GeneID) CE27379(WormBase_PRO)
O16671(Synonym) F41B5.3a(WormBase_TRS)
BX284605(EMBL) CCD70986(EMBL-CDS)
O16671_CAEEL(UniProtKB-ID)
Show All

PANTHER Classification
PANTHER Family: CYTOCHROME P450 508A4-RELATED (PTHR24300)
PANTHER Subfamily: CYTOCHROME P450 FAMILY (PTHR24300:SF375)  
PANTHER GO-slim Molecular Function: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
monooxygenase activity
heme binding
PANTHER GO-slim Biological Process: organic acid metabolic process
cellular response to chemical stimulus
PANTHER GO-slim Cellular Component: intracellular membrane-bounded organelle
cytoplasm
PANTHER protein class: oxygenase
Pathway Categories: No pathway information available
GO MF Complete: oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen, iron ion binding, oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, metal ion binding, monooxygenase activity, heme binding
GO BP Complete: organic acid metabolic process, xenobiotic metabolic process
GO CC Complete: cytoplasm, intracellular membrane-bounded organelle
Reactome Pathways: Drug ADME, Aspirin ADME, Biosynthesis of maresins, Biosynthesis of maresin-like SPMs, Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE), Aflatoxin activation and detoxification, Metabolism of lipids, Biosynthesis of DHA-derived SPMs, Xenobiotics, Biosynthesis of specialized proresolving mediators (SPMs), Metabolism, Paracetamol ADME, Cytochrome P450 - arranged by substrate type, Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET), Phase I - Functionalization of compounds, Fatty acids, CYP2E1 reactions, Fatty acid metabolism, Biological oxidations, Miscellaneous substrates, Arachidonic acid metabolism